Abstract:first_page Download PDF settings Order Article Reprints Font Type: Arial Georgia Verdana Font Size: Aa Aa Aa Line Spacing:    Column Width:    Background: Open Access Editorial The 15th Anniversary of Viruses : An Unwavering Commitment to Serving the Virology Community by Eric O. Freed Eric O. Freed SciProfiles Scilit Preprints.org Google Scholar HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201, USA Viruses 2024 , 16 (4), 486; https://doi.org/10.3390/v16040486 Submission received: 18 March 2024 / Accepted: 20 March 2024 / Published: 22 March 2024 Download keyboard_arrow_down Download PDF Download PDF with Cover Download XML Download Epub Versions Notes It is often said that two things in life are certain: death and taxes. Even without a professional interest in the subject, one might be tempted in today's world to add a third: viruses.As Viruses celebrates its 15th anniversary, this Editorial is being written against the background of a so-called 'tripledemic'—the combination of influenza virus, SARS-CoV-2, and respiratory syncytial virus. This development has triggered an increase in hospital admissions of both the very young and the very old in Europe during the winter season [1]. However, despite how much we may know about viruses, there is always more to learn, there are always surprises around every corner, and there is always more work to be done in the fields of both primary research and public health management and communication.During the past decade and a half, I have had the privilege of being Editor-in-Chief of Viruses , which was first launched in 2009 [2]. It is a role in which I take both professional pride and considerable pleasure, working on a strictly volunteer basis with the goal of creating a highly regarded and influential scientific journal that serves the continually evolving needs of the global virology community.The field of virology has faced significant new challenges and has also witnessed exciting progress in recent decades. With a current impact factor of 4.7, Viruses itself has become a leader in the publication of high-quality virology papers. To date, the journal has published 13,690 papers, 5244 of which have been cited 10 times or more. Viruses has received an increased CiteScore of 7.1 according to the 2022 CiteScoresTM released by Elsevier in June 2023. This places it in the top quartile (Q1) of the 'Infectious Diseases' category. This is a significant development, as many authors use this metric when deciding where to submit their work.The success of Viruses as a well-recognized outlet for leading virology research is founded on the quality of its distinguished and highly committed editorial team, from the Editorial Board itself to the Reviewer Board to the editorial teams that prepare individual papers for publication. The journal has a broad scope that not only covers human and animal viruses but also insect, plant, and bacterial viruses. It is also very actively engaged in a number of outreach activities in the virology community, including conference organization, meeting sponsorships, early career investigator prizes, and travel awards, to name but a few. Every two years, we organize the Viruses conference to gather insights and exchange ideas with our peers in the field. The recent Viruses 2024 Conference, held in Barcelona, Spain, from 14 to 16 February 2024, was another significant milestone in this regard. Viru -Abstract Truncated-

It's time for a booster: here's your 19th dose of Future Virology!

COVID-19 Vaccine Booster Strategies in Light of Emerging Viral Variants: Frequency, Timing, and Target Groups

The 15th Anniversary of Viruses: An Unwavering Commitment to Serving the Virology Community

It's the little things: looking forward to a new year of Future Microbiology with Volume 19

The end of the beginning: vaccines for the next 25 years

The Future of Epidemic and Pandemic Vaccines to Serve Global Public Health Needs

Updates from the Journal of Virology Editors in Chief

Navigating the Evolving Landscape of COVID-19: Strategies to Increase Vaccine Confidence and Improve Vaccination Rates in the United States

Virology under the Microscope—a Call for Rational Discourse

Exploring future perspectives and pipeline progression in vaccine research and development

Renewing an author‐centric publication process

Thank you to our reviewers 2022

Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS‐CoV‐2 Infection—Increasing Community Access to Testing Program, United States, January–September 2023

Vaccination Worldwide: Strategies, Distribution and Challenges

Editorial: HPV Natural History, Immunological Responses and Vaccination Strategies: Challenges and Opportunities

Correction for Rasmussen et al., "Virology—the path forward"

Advancing the National Immunization Program in an era of achieving universal vaccine coverage in China and beyond

Unlocking insights: Navigating COVID-19 challenges and Emulating future pandemic Resilience strategies with strengthening natural immunity

Vaccines, inspiring innovation in health

Factors, enablers and challenges for COVID-19 vaccine development

COVID-19: vaccination, therapeutics and a review of the science and public health